'Remarkable' Alzheimer's drug reduces cognitive decline, study shows
Alzheimer's progressively destroys thinking and memory, eventually robbing people of the ability to carry out the simplest of tasks.
Stay updated with breaking news from Mark Mintun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alzheimer's progressively destroys thinking and memory, eventually robbing people of the ability to carry out the simplest of tasks.
WASHINGTON, May 4 — US pharmaceutical giant Eli Lilly yesterday announced its experimental Alzheimer’s drug significantly slowed cognitive and functional decline, results...
The company Eli Lilly has reported its drug - donanemab - slows the pace of Alzheimer's by about a third.
The experimental Alzheimer's drug developed by Eli Lilly slowed down progression of the disease in a clinical trial, the company said Wednesday. Eli Lilly plans to seek FDA approval for donanemab by the end of June after submitting data showing the drug reduces cognitive and functional declines.
US pharma giant Eli Lilly's experimental Alzheimer's drug slowed clinical decline by 35 per cent compared to placebo, and resulted in 40 per cent less decline on the ability to perform activities of daily living, said the company announcing ...